LifeVest Safety and Efficacy in Real Life Settings in France (WEARIT-FR)
Post-market Clinical Follow-up Study Evaluating the Efficacy and Safety of LifeVest in Real-life Settings in France
Sponsor: Zoll Medical Corporation
Listed as NCT03319160, this observational or N/A phase trial focuses on Cardiac Arrythmias and Cardiac Event and remains completed. Sponsored by Zoll Medical Corporation, it has been updated 12 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Jan 2025 — Present [monthly]
Completed
-
Sep 2024 — Jan 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Oct 2019 — Feb 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2019 — Oct 2019 [monthly]
Active Not Recruiting
-
Dec 2018 — Apr 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Dec 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zoll Medical Corporation
For direct contact, visit the study record on ClinicalTrials.gov .